NewsRx

Search our medical news database

Biotechnology

Transgenic Plants Produce Immunogenic Hepatitis B Antigen

Published in Hepatitis Weekly, May 8th, 1995

Getting vaccinated may one day be as simple as eating your vegetables, and recent experiments show that such a day may be coming soon.

Researchers at New York's Roswell Park Cancer Institute and Texas A&M University report that hepatitis B surface antigen (HBsAg) produced by genetically engineered tobacco plants are nearly as immunogenic as the expensive yeast-derived antigens now used in commercially available hepatitis B vaccines.

"The focus of the Children's Vaccine Initiative is to encourage the discovery of technology that will make vaccines more readily available to developing countries," Y. Thanavala and colleagues wrote in the April 11, 1995,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook